Trial intelligence / Profile preview

CYT-1010 in Healthy Volunteers and in Subjects With Moderate to Severe Pain After Third Molar Extraction

NCT07905105Phase 2Recruiting

Sponsor
Cytogel Pharma
Start
Sep 2026
Primary completion
Oct 2027
Countries
1
01

Overview

A Phase 2 trial of CYT-1010 in acute postoperative pain, odontalgia, sponsored by Cytogel Pharma. Started Sep 2026; status: recruiting.

02

Drugs

CYT-1010
03

Conditions

acute postoperative painodontalgia

Beyond the preview

Go deeper on NCT07905105.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07905105.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call